Cargando…

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma

INTRODUCTION: Uveal melanoma (UM) is a rare yet deadly tumor. It is known for its high metastatic potential, which makes it one of the most aggressive and lethal cancers. Recently, immune checkpoints such as Programmed cell Death protein-1 (PD1) and Cytotoxic T-Lymphocyte-Associated significantly in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Issam Salah, Nour el Imane, Marnissi, Farida, Lakhdar, Abdelhakim, Karkouri, Mehdi, ElBelhadji, Mohamed, Badou, Abdallah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471992/ https://www.ncbi.nlm.nih.gov/pubmed/37662962 http://dx.doi.org/10.3389/fimmu.2023.1225140

Ejemplares similares

The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

TMIGD2 as a potential therapeutic target in glioma patients
por: Boulhen, Chaimae, et al.
Publicado: (2023)

High VISTA expression is linked to a potent epithelial-mesenchymal transition and is positively correlated with PD1 in breast cancer
por: Rezouki, Ibtissam, et al.
Publicado: (2023)

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
por: Miftah, Hayat, et al.
Publicado: (2023)

Uveal melanoma: Estimating prognosis
por: Kaliki, Swathi, et al.
Publicado: (2015)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer
por: Zohair, Basma, et al.
Publicado: (2023)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
por: Kone, Abdou-samad, et al.
Publicado: (2022)

A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
por: Rafii, Soumaya, et al.
Publicado: (2023)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2020)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
por: Bol, Kalijn Fredrike, et al.
Publicado: (2019)

Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
por: Wan, Qi, et al.
Publicado: (2020)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Ki-67 proliferation index to further stratify invasive breast cancer molecular subtypes: Northern African comparative cohort-study with external TCGA-BRCA and METABRIC validation
por: Akhouayri, Laila, et al.
Publicado: (2022)

Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
por: Waninger, Jessica J., et al.
Publicado: (2022)

Glioblastoma Following Treated Medulloblastoma After 29 Years in the Posterior Fossa: Case Report and Review of Literature
por: Mesbahi, Tarek, et al.
Publicado: (2022)

Expression of EZH2 in uveal melanomas patients and associations with prognosis
por: Cheng, Ying, et al.
Publicado: (2017)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

MRI of Uveal Melanoma
por: Ferreira, Teresa A., et al.
Publicado: (2019)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Uveal Melanoma Metastasis
por: Rossi, Ernesto, et al.
Publicado: (2021)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
por: Koch, Elias A. T., et al.
Publicado: (2022)

Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition
por: Liang, Xiaocui, et al.
Publicado: (2023)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients
por: Lv, Yufei, et al.
Publicado: (2022)

Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma
por: Sun, Yabin, et al.
Publicado: (2022)

Exploring the VISTA of microglia: immune checkpoints in CNS inflammation
por: Borggrewe, Malte, et al.
Publicado: (2020)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
por: Reynolds, Margaret M., et al.
Publicado: (2017)

FOXD3 Regulates VISTA Expression in Melanoma
por: Rosenbaum, Sheera R., et al.
Publicado: (2020)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
por: Heppt, Markus V., et al.
Publicado: (2019)

Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy
por: Lv, Xiaohui, et al.
Publicado: (2022)

VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma
por: Tinca, Andreea Cătălina, et al.
Publicado: (2022)

Exoresection and Endoresection for Uveal Melanoma
por: Gündüz, Kaan, et al.
Publicado: (2010)

YAP as oncotarget in uveal melanoma
por: Yu, Fa-Xing, et al.
Publicado: (2014)

DNA Methylation and Uveal Melanoma
por: Yang, Zhi-Kun, et al.
Publicado: (2018)

Role of Epigenetics in Uveal Melanoma
por: Li, Yongyun, et al.
Publicado: (2017)

Epidemiology of uveal melanoma in Brazil
por: Lucena, Evandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lfup7os1stm4elmavmgrsh4t4n